Aurobindo Pharma surges on robust Q2 earnings

The company reported 21.4% rise in its net profit at Rs.451.8 crore for the quarter ended September 30, 2015 as compared to Rs.372 crore for the same quarter in the previous year.

Aurobindo Pharma Ltd stock was up by 4% at Rs. 845. The company reported 21.4% rise in its net profit at Rs.451.8 crore for the quarter ended September 30, 2015 as compared to Rs.372 crore for the same quarter in the previous year.

The scrip opened at Rs. 790 and has touched a high and low of Rs. 848.4 and Rs. 790 respectively. So far 1062250(NSE+BSE) shares were traded on the counter. The current market cap of the company is Rs. 47490.92 crore.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 860.8 on 29-Oct-2015 and a 52 week low of Rs. 490.5 on 26-Feb-2015. Last one week high and low of the scrip stood at Rs. 854.3 and Rs. 808.5 respectively.

The promoters holding in the company stood at 53.92 % while Institutions and Non-Institutions held 34.97 % and 11.11 % respectively.

The stock is currently trading below its 50 DMA.